AV-380

· AVEO Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AV-380, covering 2026-01-08 to 2026-01-08. Get the full timeline:

Most recent: Clinical Trial Update: A Dose Escalation Study of AV-380 in Cancer Patients With Cachexia [Phase 1]